|
CYFIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.546600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.540000E-02 |
| Normal-vs-Stage2 |
9.584800E-01 |
| Normal-vs-Stage3 |
2.176000E-01 |
| Normal-vs-Stage4 |
1.989570E-01 |
| Stage1-vs-Stage2 |
1.485240E-01 |
| Stage1-vs-Stage3 |
1.162620E-03 |
| Stage1-vs-Stage4 |
2.215400E-03 |
| Stage2-vs-Stage3 |
3.576800E-01 |
| Stage2-vs-Stage4 |
3.082400E-01 |
| Stage3-vs-Stage4 |
8.991600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.452200E-01 |
| Normal-vs-AfricanAmerican |
7.781000E-01 |
| Normal-vs-Asian |
3.848800E-01 |
| Caucasian-vs-AfricanAmerican |
5.734800E-01 |
| Caucasian-vs-Asian |
2.851600E-01 |
| AfricanAmerican-vs-Asian |
2.749000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.422400E-01 |
| Normal-vs-Female |
2.783000E-01 |
| Male-vs-Female |
1.126850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.548200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.175200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.685200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.918000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.222400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.848000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.872430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.483000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.782400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.500500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.383700E-03 |
| Normal-vs-Grade 2 |
1.113200E-01 |
| Normal-vs-Grade 3 |
5.989200E-01 |
| Normal-vs-Grade 4 |
1.331250E-01 |
| Grade 1-vs-Grade 2 |
5.517800E-02 |
| Grade 1-vs-Grade 3 |
8.044900E-03 |
| Grade 1-vs-Grade 4 |
3.782400E-03 |
| Grade 2-vs-Grade 3 |
1.383520E-02 |
| Grade 2-vs-Grade 4 |
2.216600E-03 |
| Grade 3-vs-Grade 4 |
2.141600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.479390E-01 |
| Normal-vs-ccB subtype |
9.035000E-01 |
| ccA subtype-vs-ccB subtype |
9.662500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.874400E-01 |
| Normal-vs-N1 |
5.904800E-01 |
| N0-vs-N1 |
5.899400E-01 |
|
|
